Skip to main content
SpringerLink
Log in

Pharmacokinetics and Pharmacodynamics of Chemotherapy in Children: The Most Used Drugs

  • Chapter
  • First Online:
Pediatric Oncologic Pharmacy

  • 618 Accesses

Abstract

This chapter contains condensed information about each drug, as well as the pharmacokinetics and pharmacodynamics applied for oncology pharmacist’s daily routine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Taketomo C, Hodding J, Kraus D. Pediatric & neonatal dosage handbook. 21st ed. United States of America: Lexicomp; 2014.

    Google Scholar 

  2. BC Cancer Agency Drug Manual: Brentuximab vedotin. 2016. http://www.bccancer.bc.ca/drug-database-site/drug%20index/brentuximab%20vedotin_monograph_1mar2016.pdf. Accessed 18 June 2018.

  3. Roche. Product monograph: Avastin. 2018. http://www.rochecanada.com/content/dam/roche_canada/en_CA/documents/Research/ClinicalTrialsForms/Products/ConsumerInformation/MonographsandPublicAdvisories/Avastin/Avastin_PM_E.pdf. Accessed 20 June 2018.

  4. Fangusaro J, Gururangan S, Poussaint TY. Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and Irinotecan (CPT-11): A Pediatric Brain Tumor Consortium Study (PBTC-022). Cancer. 2013. https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.28343. Accessed 20 June 2018.

  5. FDA. Prescribing information: Blenoxane. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050443s036lbl.pdf. Accessed 9 Oct 2018.

  6. BC Cancer Agency Drug Manual: Busulfan. 2018. http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Busulfan%20monograph.pdf. Accessed 25 June 2018.

  7. Drugs.com: Busulfan: Professional monograph. https://www.drugs.com/monograph/busulfan.html. Accessed 25 June 2018.

  8. Schmidt CWP, de Menezes FG. Drug therapy and interactions in pediatric oncology: a pocket guide. Switzerland: Springer; 2017.

    Book  Google Scholar 

  9. Schmidt CWP. Chemotherapy in neonates and infants: pharmacological oncology for children under 1 year old. Switzerland: Springer; 2018.

    Book  Google Scholar 

  10. Yanik Ö, Gündüz K, Yavuz K, Taçyıldız N, Ünal E. Chemotherapy in retinoblastoma: current approaches. Turk J Ophthamol. 2015;45(6):259–67.

    Article  Google Scholar 

  11. Pfizer. Product monograph: carboplatin injection BP. https://www.pfizer.ca/sites/g/files/g10037206/f/201712/2017.12.13_Carboplatin_PM_E_209537.pdf. Accessed 27 June 2018.

  12. BC Cancer Agency Drug Manual: Carmustine. 2018 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Carmustine%20monograph.pdf. Accessed 28 June 2018.

  13. The American Heritage Medical Dictionary Copyright. Boston: Houghton Mifflin Company; 2007.

    Google Scholar 

  14. Pfizer. Product monograph: Cisplatin Injection BP. Canada: 2017. https://www.pfizer.ca/sites/g/files/g10037206/f/201708/CISPLATIN_pm_en.pdf. Accessed 2 July 2018

  15. FDA. Highlights of prescribing information: Cyclophosphamide. 2013. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012141s090,012142s112lbl.pdf. Accessed 5 July 2018.

  16. BC Cancer Agency Drug Manual: Cyclophosphamide. 2013 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Cyclophosphamide_monograph_1June2013_formatted.pdf. Accessed 6 July 2018.

  17. Pfizer. Product monograph: Cytosar. 2014. https://www.pfizer.ca/sites/g/files/g10017036/f/201410/cytosar-non-annotated-pm-175940-E.pdf. Accessed 6 July 2018.

  18. Pfizer. Product Monograph: Dacarbazine. 2017. https://www.pfizer.ca/sites/g/files/g10037206/f/201708/DACARBAZINE_pm_en.pdf. Accessed 9 July 2018.

  19. BC Cancer Agency Drug Manual: Dacarbazine. 2013 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Dacarbazine_monograph_1June2013_formatted.pdf. Accessed 9 July 2018.

  20. BC Cancer Agency Drug Manual: Daunorubicin. 2017 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Daunorubicin_monograph_1Feb2017.pdf. Accessed 9 July 2018.

  21. George SL, Broster S, Chisholm JC, Brock P. Docetaxel in treatment of children with refractory or relapsed hepatoblastoma. J Pediatr Hematol Oncol. 2012;34(7):e295–7.

    Article  Google Scholar 

  22. Sanofi-Adventis. Product monograph: Taxotere. 2017 (revised). http://products.sanofi.ca/en/taxotere.pdf. Accessed 11 July 2018.

  23. Pfizer. Product Monograph: Adiamycin. 2014 (revised). https://www.pfizer.ca/sites/g/files/g10017036/f/201410/adriamycin-non-annotated-pm-174734-E.pdf. Accessed 12 July 2018.

  24. Harake D, Franco V, Henkel JM, Miller TL, Lipshultz SE. Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol. 2012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870660/. Accessed 12 July 2018.

  25. Bristol-Myers Squibb: VePesid label. In: FDA. 2004. https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/019557s028lbl.pdf. Accessed 17 July 2018.

  26. Sanofi-Aventis. Product Monograph: Fludara. 2014. http://products.sanofi.ca/en/Fludara.pdf. Accessed 19 July 2018.

  27. BC Cancer Agency Drug Manual: Fludarabine. 2013 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Fludarabine_monograph_1Sept2013_formatted.pdf. Accessed 19 July 2018.

  28. Bristol-Myers Squibb Canada. Product Monograph: Hydrea (hydroxyurea). 2017 (revised). https://www.bms.com/assets/bms/ca/documents/productmonograph/HYDREA_EN_PM.pdf. Accessed 23 July 2018.

  29. Pfizer. Product Monograph: Idarubicin. https://www.pfizer.ca/sites/g/files/g10037206/f/201710/idarubicin_nonannotated_pi_176724_E.pdf. Accessed 23 July 2018.

  30. Pfizer Canada Inc. Product Monograph: Idarubicin. 2014 (revised). https://www.pfizer.ca/sites/g/files/g10017036/f/201411/idarubicin-non-annotated-pm-176724-E.pdf. Accessed 24 July 2018.

  31. BC Cancer Agency Drug Manual: Ifosfamide. 2010 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Ifosfamide_monograph_1June2010_formatted.pdf. Accessed 30 July 2018.

  32. Baxter. Product Monograph: Ifex (ifosfamide). 2012 (revised). http://www.baxter.ca/en_CA/assets/downloads/monographs/IFEX_PM_APR052012_EN.pdf. Accessed 30 July 2018.

  33. BC Cancer Agency Drug Manual: Imatinib. 2017 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Imatinib_Monograph_1Mar2017.pdf. Accessed 2 Aug 2018.

  34. Pfizer. Product Monograph: Camptosar (irinotecan hydrochloride trihydrate). https://www.pfizer.ca/sites/g/files/g10017036/f/201410/CAMPTOSAR_PM_E_156369_19Sep2012.pdf. Accessed 3 Aug 2018.

  35. Wagner L. Fifteen years of irinotecan therapy for pediatric sarcoma: where to next? Clin Sarcoma Res. 2015;5:20.

    Article  Google Scholar 

  36. BC Cancer Agency Drug Manual: Irinotecan. 2018 (revised). http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Irinotecan_monograph.pdf. Accessed 6 Aug 2018.

  37. Bristol-Myers Squibb Canada. Product Monograph: CeeNU (lomustine). https://www.bms.com/assets/bms/ca/documents/productmonograph/CeeNU_EN_PM.pdf. Accessed 7 Aug 2018.

  38. FDA. Highlights of prescribing information: Erwinase (asparaginase Erwinia chrysanthemi). 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125359s088lbl.pdf. Accessed 1 Oct 2018.

  39. Pfizer. Product Monograph: Methotrexate. 2016 (revised). https://www.pfizer.ca/sites/g/files/g10028126/f/201608/Non-Annotated_Methotrexate_PM_18_July_2016_E_0.pdf. Accessed 8 Aug 2018.

  40. Hurwitz CA, Relling MV, Weitman SD, et al. Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study. J Clin Oncol. 1993;11(12):2324–9.

    Article  CAS  Google Scholar 

  41. Geller JI, Wall D, Perentesis J, Blaney SM, Bernstein M. Phase I study of Paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376). Pediatr Blood Cancer. 2010;52(3):346–50.

    Article  Google Scholar 

  42. Schmidt CWP, de Menezes FG. Drug therapy and interactions in pediatric oncology: a pocket guide. Switzerland: Springer; 2017

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Curitiba, Paraná, Brazil

    Carolina Witchmichen Penteado Schmidt

Authors
  1. Carolina Witchmichen Penteado Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schmidt, C.W.P. (2019). Pharmacokinetics and Pharmacodynamics of Chemotherapy in Children: The Most Used Drugs. In: Pediatric Oncologic Pharmacy. Springer, Cham. https://doi.org/10.1007/978-3-030-10988-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10988-2_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10987-5

  • Online ISBN: 978-3-030-10988-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation